Crude oil remains supported by vaccine hopes, but rising Covid-19 cases and new restrictive measures could significantly reduce oil demand. The price of crude oil has advanced above $46 this November, and the current price stands around $45. Fundamental analysis: OPEC will allow to increase output by 500K bpd starting in January The U.S. Food and Drug Administration is likely to approve the coronavirus vaccine by the mid of December, and this could add another support to the price of oil. Pfizer applied for vaccine approvals, and the company announced that they could begin to distribute the vaccine in the
Full ArticleCrude oil price continues to trade above the $45 level supported by vaccine news
Invezz
0 shares
1 views
You might like
Related news coverage
Economic And Market Outlook For Coming Year – Analysis
Eurasia Review
By Chan Kung and Wei Hongxu*
Goldman Sachs recently released its investment outlook for the coming year, in which it..
-
Wall Street powers to record highs to close out 2020
Proactive Investors
-
US stocks quiet but holding near record highs at the midday point of Thursday trading
Proactive Investors
-
US stocks retreat in early trade on New Year’s Eve; weekly jobless claims decline
Proactive Investors
-
Dow climbs to record close on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
Advertisement
More coverage
Competition Is What States Make Of It: A US Strategy Toward China – Analysis
Eurasia Review
By Kaleb J. Redden*
China today represents the “most consequential long-term challenge we face as a nation.”2 While..
-
Dow Jones climbs to record close on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
-
US stocks hold firm on coronavirus vaccine and economic stimulus benefit hopes
Proactive Investors
-
Samso Insights: The new world where gloves and PPE are about protecting all workers
Proactive Investors
-
NA Proactive news snapshot: Mirasol Resources, BetterLife Pharma, Victory Resources, Todos Medical ...
Proactive Investors